Related Experiment Video
Updated: Mar 10, 2026

Low Molecular Weight Protein Enrichment on Mesoporous Silica Thin Films for Biomarker Discovery
Published on: April 17, 2012
Feature selection in clinical proteomics: with great power comes great reproducibility
Wei Wang1, Andrew C-H Sue1, Wilson W B Goh2
1School of Pharmaceutical Science and Technology, Tianjin University, China.
Abstract:
In clinical proteomics, reproducible feature selection is unattainable given the standard statistical hypothesis-testing framework. This leads to irreproducible signatures with no diagnostic power. Instability stems from high P-value variability (p_var), which is inevitable and insolvable. The impact of p_var can be reduced via power increment, for example increasing sample size and measurement accuracy. However, these are not realistic solutions in practice. Instead, workarounds using existing data such as signal boosting transformation techniques and network-based statistical testing is more practical. Furthermore, it is useful to consider other metrics alongside P-values including confidence intervals, effect sizes and cross-validation accuracies to make informed inferences.

